# Efficacy and Safety of COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept Study

> **NCT05481736** · PHASE2 · COMPLETED · sponsor: **COMPASS Pathways** · enrollment: 32 (actual)

## Conditions studied

- Anorexia Nervosa

## Interventions

- **DRUG:** Psilocybin

## Key facts

- **NCT ID:** NCT05481736
- **Lead sponsor:** COMPASS Pathways
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-12
- **Primary completion:** 2024-11-18
- **Final completion:** 2024-11-18
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2024-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05481736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05481736, "Efficacy and Safety of COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05481736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*